MR编号 | AT/H/0879/001 |
---|
药品名称 | Paclitaxel Kabi 6 mg/ml Konzentrat zur Herstellung einer Infusionslösung |
---|
活性成分 | |
---|
剂型 | Solution for infusion |
---|
上市许可持有人 | Fresenius Kabi Austria GmbH
Hafnerstraße 36
8055 Graz
Österreich
RMS transfer from UK/H/1335/001 |
---|
参考成员国 - 产品名称 | Austria (AT) |
---|
互认成员国 - 产品名称 | - United Kingdom (Northern Ireland) (XI)
PL 08828/0186 - 0032 - Germany (DE)
Paclitaxel Kabi 6 mg/ml Konzentrat zur Herstellung einer Infusionslösung - Denmark (DK)
- Belgium (BE)
- Netherlands (NL)
- Luxembourg (LU)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Sweden (SE)
- Norway (NO)
- Finland (FI)
Paclitaxel Fresenius Kabi - Poland (PL)
Paclitaxel Kabi - Latvia (LV)
Paclitaxel Kabi 6 mg/ml koncentrāts infūziju šķīduma pagatavošanai - Lithuania (LT)
Paclitaxel Kabi 6 mg/ml koncentratas infuziniam tirpalui - Estonia (EE)
- Hungary (HU)
PACLITAXEL KABI 6 mg/ml koncentrátum oldatos infúzióhoz - Bulgaria (BG)
Paclitaxel Kabi - Romania (RO)
Paclitaxel Kabi 6mg/ml concentrat pentru soluţie perfuzabilă - Slovakia (SK)
Paclitaxel Kabi 6mg/ml - Slovenia (SI)
- Czechia (CZ)
- Ireland (IE)
- France (FR)
|
---|
许可日期 | 2009/01/10 |
---|
最近更新日期 | 2024/06/13 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:[not specified]
- TypeLevel2:[not specified]
- TypeLevel3:[not specified]
- TypeLevel4:[not specified]
- TypeLevel5:[not specified]
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|